IST:SURGY Income Statement

Financials in millions TRY. Fiscal year is January - December.

Millions TRY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Selling, General & Administrative	176.32	198.85	126.94	91.98
Other Operating Expenses	-0.29	3.04	1.85	-8.46
Total Operating Expenses	176.03	201.9	128.78	83.53
Operating Income	-176.03	-201.9	-128.78	-83.53
Interest Expense	-2.27	-1.09	-	-
Interest & Investment Income	63.58	114.12	-	-
Currency Exchange Gain (Loss)	-0.84	0.36	-2.3	-0.15
Other Non-Operating Income	-74.91	-204.72	-47.55	-51.63
EBT Excluding Unusual Items	-190.47	-293.23	-178.63	-135.31
Gain (Loss) on Sale of Investments	148.26	175.76	12.76	-
Asset Writedown	909.18	909.18	1,478	747.19
Pretax Income	866.97	791.71	1,313	611.88
Income Tax Expense	-702.5	462.95	-	-
Net Income	1,569	328.76	1,313	611.88
Net Income to Common	1,569	328.76	1,313	611.88
Net Income Growth	72.39%	-74.95%	114.51%	-
Basic Shares Outstanding	168	168	168	70
Diluted Shares Outstanding	168	168	168	70
Shares Change (YoY)	-12.70%	-	139.29%	-
EPS (Basic)	9.37	1.96	7.84	8.74
EPS (Diluted)	9.37	1.96	7.84	8.74
EPS Growth	97.47%	-74.95%	-10.36%	-
EBITDA	-174.36	-200.23	-128.13	-83.47
D&A For Ebitda	1.67	1.67	0.65	0.05
EBIT	-176.03	-201.9	-128.78	-83.53
Effective Tax Rate	-	58.48%	-	-

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.